Conférences  >  Médecine & Soins de Santé  >  Pharmacogénétique, Médecine personnalisée

CRUK, ESMO, Unicancer

The Molecular Analysis for Precision Oncology Congress 2025 will take place from 15 to 16 September in Paris, France, uniting leading experts in oncology, molecular diagnostics, and precision medicine for dynamic discussions and collaboration, with a focus on decoding the molecular bases of cancer to enable precision oncology. The congress will delve into transformative topics shaping cancer research, including cancer prevention, interception, epigenetics, metastasis, and cancer evolution, offering a deeper understanding of mechanisms driving progression and resistance.

MAP Congress Team;     Tél.: [+41 (0)91 973 19 47];     Email.: map@esmo.org

molecular oncology, precision medicine, molecular diagnostics, cancer prevention, cancer interception, epigenetics, metastasis, cancer evolution, cancer resistance, artificial intelligence in oncology, cancer immunology, immunotherapy, aging and senescence, microbiome and cancer, metabolism dysregulation, therapeutic vulnerabilities, cancer research, oncology collaboration, AI-driven diagnostics, innovative cancer treatments

Cancérologie,    Médecine translationnelle, essais cliniques

Precision Medicine by Oxford Global

The Precision Medicine Awards 2025 celebrate the people and innovations driving better patient outcomes through personalised treatments. Our 16 Awards represent the pinnacle of excellence across a community of more than 40,000 R&D professionals. The Awards evening takes place on 30th September at the prestigious Church House Assembly Hall in Westminster, London, following the 20th Anniversary Biomarkers and Precision Medicine event. Join us to celebrate your achievements, light up our industry, and drive the next wave of transformation.

Marketing Executive;     Tél.: [01865 248455];     Email.: r.wheble@oxfordglobal.com

Biomarkers, Spatial Biology for precision medicine, digital pathology, AI, Biomarker Discovery, Biomarker Identification, Biomarker Validation, Clinical Biomarkers, Pre-Clinical, Translational Science, Clinical Development, Precision Medicine, Early Detection, Enabling Technologies, Multiplex Technologies, Genomic Biomarkers, Regulation, Imaging techniques, proteomics, metabolomics, multiplex tools, Spatial Transcriptomics, Spatial Proteomics, Systems Biology, Molecular Medicine, Spatial Genomics, Spatial Metabolomics, Spatial Imaging Platforms, Spatial Data Analysis Tools, Spatial Genomics. Tissue Imaging & Prep, Single Molecule Imaging, Bioinformatics, Computational Pathology, Image analysis, Biomedical Informatics & AI, Computational Medicine, Pathology IT, Immunohistochemistry, Histopathology, Toxicology and Safety Sciences, NHS transformation, Pathology, Diagnostics, Digital Pathology Hardware, Scanners, Monitors, Digital Pathology Software, Image analysis, Multi-modal image analysis, Image Management, Cloud computing/ storage, End to End Solutions, LIS, Enterprise Imaging & Healthcare IT, AI Algorithms

CHI

The ninth edition in the series overall, and second annual Food as Medicine Policy and Research Summit is the dedicated meeting point for policy makers and influencers, leading researchers, healthcare professionals, CBO’s, food brands, retailers and more to advance the critical discussions in the field. Bringing together those with deep policy and research knowledge, as well as those who are progressing along their journey, this event promises to deliver immediate actionable takeaways, tangible outcomes, and influential guidance on future plans for all those involved.

Tél.: [781.972.5400];     Email.: chi@healthtech.com